JNJ EVP Vanessa Broadhurst Exercises Options and Sells 23,054 Shares

What Happened
Vanessa Broadhurst, EVP, Global Corporate Affairs at Johnson & Johnson (JNJ), exercised stock options and immediately sold the resulting 23,054 shares on July 20, 2026. She exercised 11,129 shares at $129.51 (cost $1,441,317) and 11,925 shares at $131.94 (cost $1,573,385), for a total exercise cost of about $3,014,702. The shares were sold in the open market at a weighted average price of $251.27, producing gross sale proceeds of $5,792,686 (net proceeds before taxes/fees ≈ $2.78M).

Key Details

• Transaction date: 2026-07-20; Form 4 filed: 2026-07-21 (timely filing).
• Exercise lots: 11,129 shares @ $129.51 and 11,925 shares @ $131.94 (coded M = option exercise).
• Sale: 23,054 shares sold @ weighted avg $251.27, total proceeds $5,792,686 (coded S = open market sale).
• Reported weighted-average sale price range: $251.09–$251.555 (footnote F1).
• Award origin: options awarded under the issuer’s Long-Term Incentive Plan; options vest/are exercisable on the third anniversary of the grant date (footnote F2).
• Shares owned after the transaction: not specified in the provided filing excerpt.

Context

• This is a typical exercise-and-sell (cashless) sequence: options were exercised (conversion of derivatives) and the acquired shares were immediately sold in the open market. The Form records both the acquisition by exercise and the subsequent sale; the derivative conversion entries show $0.00 disposition per share because the option shares were converted.
• Such transactions are routine for executives exercising vested awards to realize gains or cover exercise/tax costs; they are factual disclosures and do not, by themselves, indicate company outlook.